• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码 RNA-MALAT1 通过 MYBL2/mTOR 轴调控前列腺癌中的肿瘤葡萄糖代谢。

LncRNA-MALAT1 Regulates Cancer Glucose Metabolism in Prostate Cancer via MYBL2/mTOR Axis.

机构信息

Department of Urology, Anhui Provincial Hospital, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science & Technology of China (USTC), Hefei, Anhui 230001, China.

Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China.

出版信息

Oxid Med Cell Longev. 2022 May 2;2022:8693259. doi: 10.1155/2022/8693259. eCollection 2022.

DOI:10.1155/2022/8693259
PMID:35557985
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9086835/
Abstract

It is known that the long noncoding RNAs (lncRNA) MALAT1 is associated with tumorigenesis and progression in various cancers; however, its functions and mechanisms in prostate cancer (PCa) initiation and progression are still unknown. In the present study, our findings revealed that MALAT1 plays a critical part in regulating PCa proliferation and glucose metabolism. Knockdown of MALAT1 affects the protein and mRNA levels of MYBL2. In addition, MALAT1 enhances the phosphorylation level of mTOR pathway by upregulating MYBL2. Knockdown of MALAT1 or MYBL2 in PCa cell lines significantly inhibits their proliferation capacity. Silencing MALAT1/MYBL2/mTOR axis in PCa cell lines affects their glycolysis and lactate levels, and we verified these findings in mice. Furthermore, we explored the underlying tumorigenesis functions of MYBL2 in PCa and found that high expression of MYBL2 was positively associated with TNM stage, Gleason score, PSA level, and poor survival rate in PCa patients. Taken together, our research suggests that MALAT1 controls cancer glucose metabolism and progression by upregulating MYBL2-mTOR axis.

摘要

已知长链非编码 RNA(lncRNA)MALAT1 与多种癌症的肿瘤发生和进展有关;然而,其在前列腺癌(PCa)发生和进展中的功能和机制尚不清楚。在本研究中,我们的研究结果表明 MALAT1 在调节 PCa 增殖和葡萄糖代谢中起着关键作用。敲低 MALAT1 会影响 MYBL2 的蛋白和 mRNA 水平。此外,MALAT1 通过上调 MYBL2 增强 mTOR 通路的磷酸化水平。在 PCa 细胞系中敲低 MALAT1 或 MYBL2 可显著抑制其增殖能力。在 PCa 细胞系中沉默 MALAT1/MYBL2/mTOR 轴会影响其糖酵解和乳酸水平,我们在小鼠中验证了这些发现。此外,我们探索了 MYBL2 在 PCa 中的潜在肿瘤发生功能,发现 MYBL2 的高表达与 PCa 患者的 TNM 分期、Gleason 评分、PSA 水平和不良生存率呈正相关。综上所述,我们的研究表明 MALAT1 通过上调 MYBL2-mTOR 轴来控制癌症的葡萄糖代谢和进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb5f/9086835/c020295c39fe/OMCL2022-8693259.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb5f/9086835/5ec90d13258f/OMCL2022-8693259.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb5f/9086835/b7ac1392b9c5/OMCL2022-8693259.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb5f/9086835/e6a41bc40a33/OMCL2022-8693259.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb5f/9086835/deec88d50e55/OMCL2022-8693259.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb5f/9086835/c5c59ed7ca8f/OMCL2022-8693259.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb5f/9086835/b60cb657dd57/OMCL2022-8693259.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb5f/9086835/c020295c39fe/OMCL2022-8693259.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb5f/9086835/5ec90d13258f/OMCL2022-8693259.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb5f/9086835/b7ac1392b9c5/OMCL2022-8693259.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb5f/9086835/e6a41bc40a33/OMCL2022-8693259.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb5f/9086835/deec88d50e55/OMCL2022-8693259.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb5f/9086835/c5c59ed7ca8f/OMCL2022-8693259.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb5f/9086835/b60cb657dd57/OMCL2022-8693259.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb5f/9086835/c020295c39fe/OMCL2022-8693259.007.jpg

相似文献

1
LncRNA-MALAT1 Regulates Cancer Glucose Metabolism in Prostate Cancer via MYBL2/mTOR Axis.长链非编码 RNA-MALAT1 通过 MYBL2/mTOR 轴调控前列腺癌中的肿瘤葡萄糖代谢。
Oxid Med Cell Longev. 2022 May 2;2022:8693259. doi: 10.1155/2022/8693259. eCollection 2022.
2
Long Noncoding RNA MALAT1 Regulates Cancer Glucose Metabolism by Enhancing mTOR-Mediated Translation of TCF7L2.长链非编码 RNA MALAT1 通过增强 mTOR 介导的 TCF7L2 翻译来调节癌症葡萄糖代谢。
Cancer Res. 2019 May 15;79(10):2480-2493. doi: 10.1158/0008-5472.CAN-18-1432. Epub 2019 Mar 26.
3
MALAT1 knockdown inhibits prostate cancer progression by regulating miR-140/BIRC6 axis.MALAT1 knockdown 通过调控 miR-140/BIRC6 轴抑制前列腺癌进展。
Biomed Pharmacother. 2020 Mar;123:109666. doi: 10.1016/j.biopha.2019.109666. Epub 2020 Jan 11.
4
Long noncoding RNA MALAT1 enhances the docetaxel resistance of prostate cancer cells via miR-145-5p-mediated regulation of AKAP12.长链非编码 RNA MALAT1 通过 miR-145-5p 介导的 AKAP12 调控增强前列腺癌细胞对多西他赛的耐药性。
J Cell Mol Med. 2018 Jun;22(6):3223-3237. doi: 10.1111/jcmm.13604. Epub 2018 Apr 6.
5
Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.长链非编码 RNA ZEB1-AS1 下调通过 miR-342-3p/CUL4B 轴调控 PI3K/AKT/mTOR 信号通路抑制前列腺癌细胞增殖、迁移和侵袭。
Cancer Biother Radiopharm. 2020 Nov;35(9):661-672. doi: 10.1089/cbr.2019.3123. Epub 2020 Apr 9.
6
MYBL2 disrupts the Hippo-YAP pathway and confers castration resistance and metastatic potential in prostate cancer.MYBL2 破坏 Hippo-YAP 通路,赋予前列腺癌去势抵抗和转移潜能。
Theranostics. 2021 Mar 31;11(12):5794-5812. doi: 10.7150/thno.56604. eCollection 2021.
7
[High expression of MYBL2 promotes progression and predicts a poor survival outcome of prostate cancer].MYBL2高表达促进前列腺癌进展并预示不良生存结局
Nan Fang Yi Ke Da Xue Xue Bao. 2022 Aug 20;42(8):1109-1118. doi: 10.12122/j.issn.1673-4254.2022.08.01.
8
LncRNA LOXL1-AS1 regulates the tumorigenesis and development of lung adenocarcinoma through sponging miR-423-5p and targeting MYBL2.长链非编码 RNA LOXL1-AS1 通过海绵吸附 miR-423-5p 和靶向 MYBL2 调节肺腺癌的发生发展。
Cancer Med. 2020 Jan;9(2):689-699. doi: 10.1002/cam4.2641. Epub 2019 Nov 23.
9
Interaction of lncRNA-MALAT1 and miR-124 regulates HBx-induced cancer stem cell properties in HepG2 through PI3K/Akt signaling.lncRNA-MALAT1 与 miR-124 的相互作用通过 PI3K/Akt 信号通路调节 HBx 诱导的 HepG2 肿瘤干细胞特性。
J Cell Biochem. 2019 Mar;120(3):2908-2918. doi: 10.1002/jcb.26823. Epub 2018 Nov 30.
10
Circular RNA circMBOAT2 promotes prostate cancer progression via a miR-1271-5p/mTOR axis.环状 RNA circMBOAT2 通过 miR-1271-5p/mTOR 轴促进前列腺癌进展。
Aging (Albany NY). 2020 Jul 9;12(13):13255-13280. doi: 10.18632/aging.103432.

引用本文的文献

1
Regulatory role of the METTL3/MALAT1 axis in multiple myeloma progression.METTL3/MALAT1轴在多发性骨髓瘤进展中的调控作用。
J Bone Oncol. 2025 Jun 12;53:100695. doi: 10.1016/j.jbo.2025.100695. eCollection 2025 Aug.
2
Mechanisms and progress of LncRNAs in prostate cancer development and diagnostic therapy.长链非编码RNA在前列腺癌发生发展及诊断治疗中的机制与进展
Int Urol Nephrol. 2025 Apr 23. doi: 10.1007/s11255-025-04497-z.
3
Role of multi‑omics in advancing the understanding and treatment of prostate cancer (Review).多组学在促进前列腺癌理解与治疗中的作用(综述)

本文引用的文献

1
Elevated expression of the MYB proto-oncogene like 2 (MYBL2)-encoding gene as a prognostic and predictive biomarker in human cancers.MYB 原癌基因样 2(MYBL2)编码基因表达升高可作为人类癌症的预后和预测生物标志物。
Math Biosci Eng. 2022 Jan;19(2):1825-1842. doi: 10.3934/mbe.2022085. Epub 2021 Dec 17.
2
CENPA is one of the potential key genes associated with the proliferation and prognosis of ovarian cancer based on integrated bioinformatics analysis and regulated by MYBL2.基于综合生物信息学分析,CENPA是与卵巢癌增殖和预后相关的潜在关键基因之一,并受MYBL2调控。
Transl Cancer Res. 2021 Sep;10(9):4076-4086. doi: 10.21037/tcr-21-175.
3
Mol Med Rep. 2025 May;31(5). doi: 10.3892/mmr.2025.13495. Epub 2025 Mar 21.
4
LINC01224 promotes the Warburg effect in gastric cancer by activating the miR-486-5p/PI3K axis.LINC01224通过激活miR-486-5p/PI3K轴促进胃癌的瓦伯格效应。
In Vitro Cell Dev Biol Anim. 2025 Feb;61(2):228-244. doi: 10.1007/s11626-024-01001-2. Epub 2025 Jan 28.
5
LIMD1-AS1 promotes the progression of prostate cancer and affects the function of prostate cancer cells by down-regulating miR-29c-3p.LIMD1-AS1通过下调miR-29c-3p促进前列腺癌进展并影响前列腺癌细胞功能。
J Cancer Res Clin Oncol. 2024 Dec 5;151(1):5. doi: 10.1007/s00432-024-06046-0.
6
Deciphering the nexus between long non-coding RNAs and endoplasmic reticulum stress in hepatocellular carcinoma: biomarker discovery and therapeutic horizons.解析长链非编码RNA与肝细胞癌内质网应激之间的联系:生物标志物发现与治疗前景
Cell Death Discov. 2024 Oct 24;10(1):451. doi: 10.1038/s41420-024-02200-2.
7
Glycolysis-associated lncRNAs in cancer energy metabolism and immune microenvironment: a magic key.癌症能量代谢和免疫微环境中与糖酵解相关的长非编码 RNA:一把神奇的钥匙。
Front Immunol. 2024 Sep 13;15:1456636. doi: 10.3389/fimmu.2024.1456636. eCollection 2024.
8
The correlation between the MYBL2/CDCA8 signaling pathway of malignant melanoma.恶性黑色素瘤的MYBL2/CDCA8信号通路之间的相关性。
Heliyon. 2024 Jun 5;10(11):e32485. doi: 10.1016/j.heliyon.2024.e32485. eCollection 2024 Jun 15.
9
Long non-coding RNA LINC00930 targeting miR-6792-3p/ZBTB16 regulates the proliferation and EMT of pancreatic cancer.长非编码 RNA LINC00930 靶向 miR-6792-3p/ZBTB16 调控胰腺癌的增殖和 EMT。
BMC Cancer. 2024 May 24;24(1):638. doi: 10.1186/s12885-024-12365-9.
10
Long noncoding RNA MALAT-1: A versatile regulator in cancer progression, metastasis, immunity, and therapeutic resistance.长链非编码RNA MALAT-1:癌症进展、转移、免疫及治疗抗性中的多功能调节因子
Noncoding RNA Res. 2024 Feb 1;9(2):388-406. doi: 10.1016/j.ncrna.2024.01.015. eCollection 2024 Jun.
Cancer statistics, 2022.
癌症统计数据,2022 年。
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.
4
Progression and metastasis of small cell lung carcinoma: the role of the PI3K/Akt/mTOR pathway and metabolic alterations.小细胞肺癌的进展和转移:PI3K/Akt/mTOR 通路和代谢改变的作用。
Cancer Metastasis Rev. 2021 Dec;40(4):1141-1157. doi: 10.1007/s10555-021-10012-4. Epub 2021 Dec 27.
5
LncRNA MALAT1 promotes breast cancer progression by sponging miR101-3p to mediate mTOR/PKM2 signal transmission.长链非编码RNA MALAT1通过吸附miR101-3p介导mTOR/PKM2信号传导来促进乳腺癌进展。
Am J Transl Res. 2021 Sep 15;13(9):10262-10275. eCollection 2021.
6
Pharmacological inhibition of arachidonate 12-lipoxygenase ameliorates myocardial ischemia-reperfusion injury in multiple species.药物抑制花生四烯酸 12-脂氧合酶可改善多种物种的心肌缺血再灌注损伤。
Cell Metab. 2021 Oct 5;33(10):2059-2075.e10. doi: 10.1016/j.cmet.2021.08.014. Epub 2021 Sep 17.
7
CCL21 activation of the MALAT1/SRSF1/mTOR axis underpins the development of gastric carcinoma.CCL21 激活 MALAT1/SRSF1/mTOR 轴,为胃癌的发展提供了基础。
J Transl Med. 2021 May 17;19(1):210. doi: 10.1186/s12967-021-02806-5.
8
MYBL2 disrupts the Hippo-YAP pathway and confers castration resistance and metastatic potential in prostate cancer.MYBL2 破坏 Hippo-YAP 通路,赋予前列腺癌去势抵抗和转移潜能。
Theranostics. 2021 Mar 31;11(12):5794-5812. doi: 10.7150/thno.56604. eCollection 2021.
9
[Relationship between long non-coding RNA MALAT1 and prostate cancer].长链非编码RNA MALAT1与前列腺癌的关系
Zhonghua Nan Ke Xue. 2020 Feb;26(2):174-179.
10
The miR-30a-5p/CLCF1 axis regulates sorafenib resistance and aerobic glycolysis in hepatocellular carcinoma.miR-30a-5p/CLCF1 轴调控肝癌索拉非尼耐药及有氧糖酵解
Cell Death Dis. 2020 Oct 23;11(10):902. doi: 10.1038/s41419-020-03123-3.